210 related articles for article (PubMed ID: 24715427)
21. Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: an immunohistochemical analysis.
Morgan TK; Zhao S; Chang KL; Haddix TL; Domanay E; Cornbleet PJ; Arber DA; Natkunam Y
Am J Clin Pathol; 2006 Oct; 126(4):545-51. PubMed ID: 16938662
[TBL] [Abstract][Full Text] [Related]
22. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
[TBL] [Abstract][Full Text] [Related]
23. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
Xu K; Nacheva E
J Hematop; 2024 Jun; 17(2):117-119. PubMed ID: 38580782
[TBL] [Abstract][Full Text] [Related]
24. Antigenic transformation in plasma cell dyscrasia.
Cruse JM; Lewis RE; Webb RN; Sanders CM; Tillman BF; Beason K; Lam J; Koehler J
Exp Mol Pathol; 2006 Oct; 81(2):157-61. PubMed ID: 16908019
[TBL] [Abstract][Full Text] [Related]
25. Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
Muccio VE; Saraci E; Gilestro M; Gattei V; Zucchetto A; Astolfi M; Ruggeri M; Marzanati E; Passera R; Palumbo A; Boccadoro M; Omedè P
Cytometry B Clin Cytom; 2016 Jan; 90(1):81-90. PubMed ID: 26287276
[TBL] [Abstract][Full Text] [Related]
26. Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma.
Reid S; Yang S; Brown R; Kabani K; Aklilu E; Ho PJ; Woodland N; Joshua D
Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e190-6. PubMed ID: 20201998
[TBL] [Abstract][Full Text] [Related]
27. Impact of CD138 Magnetic Bead-based Positive Selection on Bone Marrow Plasma Cell Surface Markers.
Bansal R; Kimlinger T; Gyotoku KA; Smith M; Rajkumar V; Kumar S
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e48-e51. PubMed ID: 32873534
[TBL] [Abstract][Full Text] [Related]
28. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.
Gangadhar P; Ahmed Z; Pai MR; Sandhya I
Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294
[TBL] [Abstract][Full Text] [Related]
29. Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
Kovarova L; Buresova I; Buchler T; Suska R; Pour L; Zahradova L; Penka M; Hajek R
Neoplasma; 2009; 56(6):526-32. PubMed ID: 19728762
[TBL] [Abstract][Full Text] [Related]
30. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C
Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric immunophenotypic characteristics of plasma cell leukemia.
Kraj M; Kopeć-Szlęzak J; Pogłód R; Kruk B
Folia Histochem Cytobiol; 2011; 49(1):168-82. PubMed ID: 21526505
[TBL] [Abstract][Full Text] [Related]
32. Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells.
Jeong TD; Park CJ; Shim H; Jang S; Chi HS; Yoon DH; Kim DY; Lee JH; Lee JH; Suh C; Lee KH
Korean J Hematol; 2012 Dec; 47(4):260-6. PubMed ID: 23320004
[TBL] [Abstract][Full Text] [Related]
33. Primary Plasma Cell Leukemia Associated with t(6;14)(p21;q32) and IGH Rearrangement: A Case Study and Review of the Literature.
Cho SY; Lim G; Oh SH; Lee HJ; Suh JT; Lee J; Lee WI; Lee HG; Yoon HJ; Park TS
Ann Clin Lab Sci; 2011; 41(3):277-81. PubMed ID: 22075513
[TBL] [Abstract][Full Text] [Related]
34. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
van Velzen JF; van den Blink D; Bloem AC
Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
[TBL] [Abstract][Full Text] [Related]
35. Oligosecretory Primary Plasma Cell Leukemia with Atypical Morphological Abnormality.
Toriyama E; Imaizumi Y; Tsuruda K; Itonaga H; Sato S; Ando K; Sawayama Y; Hasegawa H; Hata T; Niino D; Yanagihara K; Miyazaki Y
Intern Med; 2019 Aug; 58(15):2213-2217. PubMed ID: 30996175
[TBL] [Abstract][Full Text] [Related]
36. Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: a case report.
Naushad H; Choi WW; Page CJ; Sanger WG; Weisenburger DD; Aoun P
Cytometry B Clin Cytom; 2009 May; 76(3):218-24. PubMed ID: 19061249
[TBL] [Abstract][Full Text] [Related]
37. Primary plasma cell leukemia mimicking an adult T-cell leukemia-lymphoma: a case report.
Delhommeau F; Huguet S; Gachet J; van den Akker J; Lagrange M
Acta Cytol; 2010; 54(2):187-9. PubMed ID: 20391976
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.
Lin P; Owens R; Tricot G; Wilson CS
Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299
[TBL] [Abstract][Full Text] [Related]
39. An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138(+) cells.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Ikemoto T; Tanaka H; Nishimura Y; Tsuji M; Hanafusa T
Diagn Pathol; 2012 Sep; 7():131. PubMed ID: 23021410
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic profile of plasma cell leukemia: a retrospective study in a reference cancer center in India and review of literature.
Tembhare PR; Subramanian PG; Sehgal K; Yajamanam B; Kumar A; Gadge V; Inamdar N; Gujral S
Indian J Pathol Microbiol; 2011; 54(2):294-8. PubMed ID: 21623077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
